Cargando…
PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways
BACKGROUND: Esophageal carcinogenesis is a multifactorial process in which genetic and environmental factors interact to activate intracellular signals, leading to the uncontrolled survival and growth of esophageal squamous cell carcinoma (ESCC) cells. The intracellular pathways of ESCC cells could...
Autores principales: | Zhao, Jia, Jin, Guangyu, Liu, Xudong, Wu, Kai, Yang, Yang, He, Zhanfeng, Liu, Donglei, Zhang, Chunyang, Zhu, Dengyan, Jiao, Jia, Li, Xiangnan, Zhao, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628382/ https://www.ncbi.nlm.nih.gov/pubmed/34844621 http://dx.doi.org/10.1186/s12935-021-02354-4 |
Ejemplares similares
-
Silencing of histone deacetylase 3 suppresses the development of esophageal squamous cell carcinoma through regulation of miR-494-mediated TGIF1
por: Yang, Yang, et al.
Publicado: (2022) -
Effect of YAP1 silencing on esophageal cancer
por: Zhao, Jia, et al.
Publicado: (2016) -
Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells
por: DANG, LIFENG, et al.
Publicado: (2014) -
Long noncoding RNA PART1 promotes progression of non‐small cell lung cancer cells via JAK‐STAT signaling pathway
por: Zhu, Dengyan, et al.
Publicado: (2019) -
Long Non-coding RNA CASC2 Enhances the Antitumor Activity of Cisplatin Through Suppressing the Akt Pathway by Inhibition of miR-181a in Esophageal Squamous Cell Carcinoma Cells
por: Zhu, Dengyan, et al.
Publicado: (2019)